{"References": [{"title": "Dual-targeted CAR T cells for CD19 and CD22 provide improved anti-leukemia activity and ameliorate antigen negative relapses", "authors": "Shuang Qin, Linjie Xu, Jianlin Yi, Robert H. Scheuplein, Keli Lin, Sandhya Ramakrishna, Sattva S. Neelapu, Laurence J. N. Cooper, Michael L. Wang, Chantale Bernatchez, Helen E. Heslop, Gianpietro Dotti, Barbara Savoldo", "journal": "Nature Communications", "year": "2021", "volumes": "12", "first page": "865", "last page": "", "DOI": "10.1038/s41467-021-21164-w"}, {"title": "Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production", "authors": "Kristin C. Hicks, Hua Miao, Gabrielle C. DeBenedette, Jianfeng Du, Erin Gunther, Tatyana Horev, Rui-Ru Ji, Jenna Krasner, Linjie Xu, Yan Zhou, Sattva S. Neelapu, Michael L. Wang, Laurence J. N. Cooper, Gianpietro Dotti, Barbara Savoldo", "journal": "Molecular Therapy", "year": "2020", "volumes": "28", "first page": "1280", "last page": "1294", "DOI": "10.1016/j.ymthe.2020.02.009"}, {"title": "CD19/CD22 Dual-Targeted CAR T-Cell Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A First-in-Human Clinical Trial", "authors": "Jing Pan, Jia-Ying Niu, Bian-Zheng Deng, Xiao-Li Liu, Wen-Xue Li, Zhen-Gang Peng", "journal": "Blood", "year": "2019", "volumes": "134", "first page": "283", "last page": "", "DOI": "10.1182/blood-2019-122273"}, {"title": "Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies", "authors": "Loretta J. Ruella, David M. Barrett, Saad S. Kenderian, Olga Shestova, Ted J. Hofmann, Jessica Perazzelli, Michael Klichinsky, Vanja Aikawa, Farzana Nazimuddin, Miroslaw Kozlowski, John Scholler, Simon F. Lacey, Jan J. Melenhorst, John J. Morrissette, David A. Christian, Christopher A. Hunter, Michael Kalos, David L. Porter, Carl H. June, Stephan A. Grupp, Saar Gill", "journal": "Journal of Clinical Investigation", "year": "2016", "volumes": "126", "first page": "3814", "last page": "3826", "DOI": "10.1172/JCI87366"}, {"title": "Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models", "authors": "Hua Zhang, Zeguo Zhao, Peng Wang, Zhenguang Wang, Xianghui Gao, Yao Wang, Yajing Zhang, Weidong Han", "journal": "Science Translational Medicine", "year": "2021", "volumes": "13", "first page": "eabc6401", "last page": "", "DOI": "10.1126/scitranslmed.abc6401"}, {"title": "CD19/CD22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory B Cell Malignancies: A Phase 1 Study", "authors": "Jae H. Park, Isabelle Rivière, Xiuyan Wang, Brigitte Senechal, Yongzeng Wang, Terence Purdon, Renier Brentjens, Michel Sadelain", "journal": "Blood", "year": "2018", "volumes": "132", "first page": "490", "last page": "", "DOI": "10.1182/blood-2018-99-110623"}, {"title": "Targeting B cell malignancies with CAR T cells generated from autologous T cells or cord blood T cells", "authors": "Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, John M. Timmerman, Patrick J. Stiff, Jonathan W. Friedberg, Ian W. Flinn, Andre Goy, Brian T. Hill, Mitchell R. Smith, Alison Deol, Umar Farooq, Peter McSweeney, Javier Munoz, Irit Avivi, Julio C. Chavez, Jason R. Westin, Nitin Jain, Loretta J. Nastoupil, Lihua E. Budde, Michael D. Neelapu, Yizhou Jiang, Jeff Wiezorek, William Y. Go", "journal": "Nature Medicine", "year": "2020", "volumes": "26", "first page": "770", "last page": "778", "DOI": "10.1038/s41591-020-0811-9"}, {"title": "Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia", "authors": "Shannon L. Maude, Noelle Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy J. Bunin, Anne Chew, Vanessa E. Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, Jan J. Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp", "journal": "New England Journal of Medicine", "year": "2014", "volumes": "371", "first page": "1507", "last page": "1517", "DOI": "10.1056/NEJMoa1407222"}, {"title": "CD19 CAR T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities, long-term outcomes, and event-free survival", "authors": "Jae H. Park, Isabelle Rivière, Marco L. Davila, Xiuyan Wang, Brigitte Senechal, Terence Purdon, Kevin Curran, Yvette Sauter, Melissa Sadelain, Michel Sadelain, Renier Brentjens", "journal": "Blood", "year": "2018", "volumes": "132", "first page": "2130", "last page": "2136", "DOI": "10.1182/blood-2018-02-834226"}, {"title": "Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib", "authors": "James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P. T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Adrian Goy, Tatyana Feldman, David E. Spaner, Michael L. Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg", "journal": "Journal of Clinical Oncology", "year": "2017", "volumes": "35", "first page": "1882", "last page": "1890", "DOI": "10.1200/JCO.2017.72.8519"}]}